Recovery of Ca2+ signals in prostate cancer cells is dependent on SERCA [46] and the activity of SERCA could be altered with TMCO1 silencing as our LC-MS/MS studies identified SERCA2 (ATP2A2) as an interacting partner with TMCO1. The gene discussed is ATP2A2; the disease is Familial prostate cancer.